United Therapeutics Corporation
1110 Spring Street
Silver Spring
Maryland
20910
United States
Tel: 301-608-9292
Fax: 301-608-9291
Website: http://www.unither.com/
395 articles about United Therapeutics Corporation
-
United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
2/15/2011
-
United Therapeutics Corporation to Announce Fourth Quarter and Annual 2010 Financial Results Before Market Open on Tuesday, February 15, 2011
2/8/2011
-
United Therapeutics Corporation Completes Enrollment of FREEDOM-M Trial
2/2/2011
-
United Therapeutics Corporation Reports Third Quarter 2010 Financial Results
10/28/2010
-
United Therapeutics Corporation to Announce Third Quarter 2010 Financial Results Before Market Open on Thursday, October 28, 2010
10/22/2010
-
United Therapeutics Corporation Reports Second Quarter 2010 Financial Results
7/28/2010
-
United Therapeutics Corporation to Announce Second Quarter 2010 Financial Results Before Market Open on Wednesday, July 28, 2010
7/21/2010
-
United Therapeutics Corporation and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China
7/6/2010
-
United Therapeutics Corporation Reports First Quarter 2010 Financial Results
4/29/2010
-
United Therapeutics Corporation To Announce First Quarter 2010 Financial Results Before Market Open on Thursday, April 29, 2010
4/22/2010
-
United Therapeutics Corporation Pulls Tyvaso Drug Application in EU
2/19/2010
-
United Therapeutics Corporation Reports 2009 Fourth Quarter and Annual Financial Results
2/16/2010
-
Lung Rx LLC, A Subsidiary Of United Therapeutics Corporation, And Mondobiotech Announce Today a Global Strategic Partnership Agreement for the Development Of Aviptadil Platform
2/3/2010
-
United Therapeutics Corporation Reports Third Quarter 2009 Financial Results
10/29/2009
-
United Therapeutics Corporation Reports Second Quarter 2009 Financial Results
7/31/2009
-
United Therapeutics Corporation Release: FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
7/31/2009
-
United Therapeutics Corporation to Announce Second Quarter 2009 Financial Results Before Market Open on Friday, July 31, 2009
7/24/2009
-
United Therapeutics Corporation: Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
6/9/2009
-
United Therapeutics Corporation Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
6/9/2009
-
United Therapeutics Corporation Gets FDA Nod for Oral PAH Drug
5/26/2009